Two advanced master’s degree programs, designed for mid-career professionals, will welcome their first cohorts in fall 2026.
The 12-week U.S. Phase IIa study is evaluating the efficacy, safety and tolerability of the once-monthly subcutaneous (SQ) depot formulation (treatment formulation) of small molecule ...
The National Testing Agency will be conducting the Joint Entrance Examination (Main)-2026 in two sessions,” said NTA in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback